Boditech Med Inc. (206640.KQ)

KRW 17340.0

(0.29%)

Long Term Debt Summary of Boditech Med Inc.

Boditech Med Inc.'s latest annual long term debt in 2023 was 2.09 Billion KRW , down -8.7% from previous year.
Boditech Med Inc.'s latest quarterly long term debt in 2024 Q2 was 1.96 Billion KRW , down -3.28% from previous quarter.
Boditech Med Inc. reported annual long term debt of 2.3 Billion KRW in 2022, up 43.75% from previous year.
Boditech Med Inc. reported annual long term debt of 1.6 Billion KRW in 2021, down -42.86% from previous year.
Boditech Med Inc. reported quarterly long term debt of 1.96 Billion KRW for 2024 Q2, down -3.28% from previous quarter.
Boditech Med Inc. reported quarterly long term debt of 2.23 Billion KRW for 2023 Q2, down -2.9% from previous quarter.

Annual Long Term Debt Chart of Boditech Med Inc. (2023 - 2015)

Historical Annual Long Term Debt of Boditech Med Inc. (2023 - 2015)

Year	Long Term Debt	Long Term Debt Growth
2023	2.09 Billion KRW	-8.7%
2022	2.3 Billion KRW	43.75%
2021	1.6 Billion KRW	-42.86%
2020	2.8 Billion KRW	-31.39%
2019	4.08 Billion KRW	-78.62%
2018	19.08 Billion KRW	12.64%
2017	16.94 Billion KRW	0.0%
2016	- KRW	-100.0%
2015	9.39 Billion KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	2.03 Billion KRW	-3.17%
2024 Q2	1.96 Billion KRW	-3.28%
2023 Q2	2.23 Billion KRW	-2.9%
2023 Q4	2.09 Billion KRW	-3.08%
2023 FY	2.09 Billion KRW	-8.7%
2023 Q3	2.16 Billion KRW	-2.98%
2023 Q1	2.3 Billion KRW	0.0%
2022 Q1	1 Billion KRW	-37.5%
2022 Q3	2.3 Billion KRW	0.0%
2022 Q2	2.3 Billion KRW	130.0%
2022 Q4	2.3 Billion KRW	0.0%
2022 FY	2.3 Billion KRW	43.75%
2021 FY	1.6 Billion KRW	-42.86%
2021 Q1	2.5 Billion KRW	-27.75%
2021 Q2	2.2 Billion KRW	-12.0%
2021 Q3	1.9 Billion KRW	-13.64%
2021 Q4	1.6 Billion KRW	-15.79%
2020 Q2	3.8 Billion KRW	105.0%
2020 Q4	3.45 Billion KRW	-15.29%
2020 Q3	4.08 Billion KRW	7.32%
2020 Q1	1.85 Billion KRW	-64.65%
2020 FY	2.8 Billion KRW	-31.39%
2019 Q2	5.95 Billion KRW	-71.99%
2019 FY	4.08 Billion KRW	-78.62%
2019 Q4	5.25 Billion KRW	-6.49%
2019 Q3	5.61 Billion KRW	-5.69%
2019 Q1	21.26 Billion KRW	11.41%
2018 Q2	17.31 Billion KRW	19.05%
2018 FY	19.08 Billion KRW	12.64%
2018 Q4	19.08 Billion KRW	8.31%
2018 Q1	14.54 Billion KRW	2.48%
2018 Q3	17.62 Billion KRW	1.75%
2017 FY	16.94 Billion KRW	0.0%
2017 Q1	619.54 Million KRW	0.0%
2017 Q2	12.9 Billion KRW	1983.51%
2017 Q3	13.24 Billion KRW	2.64%
2017 Q4	14.19 Billion KRW	7.14%
2016 Q3	950 Million KRW	-36.87%
2016 Q1	1.9 Billion KRW	-29.34%
2016 Q2	1.5 Billion KRW	-20.83%
2016 FY	- KRW	-100.0%
2016 Q4	- KRW	-100.0%
2015 Q3	2.67 Billion KRW	0.0%
2015 FY	9.39 Billion KRW	0.0%
2015 Q4	2.68 Billion KRW	0.37%

Peer Long Term Debt Comparison of Boditech Med Inc.

Name	Long Term Debt	Long Term Debt Difference
HLB Pharmaceutical Co., Ltd	988.75 Million KRW	-112.382%
CMG Pharmaceutical Co., Ltd.	19.06 Billion KRW	88.985%
Celltrion Pharm, Inc.	4.33 Billion KRW	51.54%
Huons Global Co., Ltd.	66.94 Billion KRW	96.863%
DongKook Pharmaceutical Co., Ltd.	18.74 Billion KRW	88.8%
Enzychem Lifesciences Corporation	1.02 Billion KRW	-104.872%
Humedix Co., Ltd.	1.75 Billion KRW	-19.632%
EuBiologics Co., Ltd.	2.8 Billion KRW	25.002%
FutureChem Co.,Ltd	2.61 Billion KRW	19.843%
Huons Co., Ltd.	58.35 Billion KRW	96.401%
BNC Korea Co., Ltd.	301.69 Million KRW	-596.058%
AptaBio Therapeutics Inc.	13.56 Billion KRW	84.525%